Swedish Multiple Sclerosis Blog
Yoga is BACK! Please join us Tuesdays for Gentle Yoga and Wellness classes with new instructor, Sharon Lightfoot-Pound. Appropriate for all mobility levels and those brand new to Yoga. Transitioning to the floor is optional; wheelchairs are welcome.
When: Starting in September, Tuesdays 1 - 2:15 PM
Although a lifelong disease, the event hopes to convey that multiple sclerosis (MS) is not life-ending. Resources are available to support patients and their families. The Swedish MS Center goes beyond health care to assist people living with MS and related neurological conditions and to help them achieve their highest level of well-being.
When: Saturday, August 23rd, Noon-5 p.m.
Where: Swedish MS Center
1600 E. Jefferson Street, Level A
Seattle, WA 98122
Cyclists participating in Bike the US for MS arrived at the Peddler Brewing Company in Ballard, Washington last Monday, some having travelled all the way from Bar Harbor, Maine. There to greet the cyclists was Dr. James Bowen, Swedish Multiple Sclerosis (MS) Center Neurologist and Medical Director. To date, the bike tour has contributed $80,000 to the Swedish MS Center helping ensure that patients in the Pacific Northwest have access to vital MS services today as well as into the future.
Bike the US for MS is ...
The Swedish Multiple Sclerosis Center is hosting the 5th annual MS Center Art Show on August 9 & 10 from 10 am to 6 pm at the Seattle Center Armory. The event is free and open to the public. Please join us for this yearly celebration of art that is created by people living with MS and all others affected by this disease.
Art frees the spirit even when MS tries to limit it. The MS Center at Swedish hopes to acknowledge the lives and talents of everyone affected by MS. The Art Show will feature over 80 pieces of art including painting, photography, sculpture, jewelry, and more.
The purpose of the annual Swedish MS Center Art Show is to:
No treatments can currently abate the advanced stage of the disease, known as secondary progressive MS, which gradually causes patients to become more disabled. Statins are postulated to have immunomodulatory effects that appear to be independent of their effect on cholesterol. A benefit has been suggested in early multiple sclerosis (MS) based on reduction of magnetic resonance imaging brain lesions. However, following trials have had inconsistent results.
In this multicenter, double-blind study, investigators randomized 140 participants with secondary progressive (SP) MS to 80 mg of simvastatin or placebo daily for 2 years. Participants were 18 to 65 years old, had active progression over the preceding 2 years, and had difficulties ambulating but were not wheelchair bound. Whole brain atrophy was 43% slower annually in simvastatin recipients than in placebo recipients. The simvastatin group also had small clinical improvements over placebo on the disability scale and a patient-reported MS impact scale at 24 months.
These findings show that simvastatin reduced ...